Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission

Table 3 Oocyst-based estimates of human infectiousness ( Ko)

	Time Period (Anti-malarial in use)	Ko	[95%CI]
Rufiji
An funestus	January 2002-February 2003 (SP)	0.011	[0.000 - 0.016]
	March 2003-September 2004 (AS + SP)	0.029	[0.013 - 0.054]
An gambiae s.l.	January 2002-February 2003 (SP)	0.006	[−0.009 - 0.013]
	March 2003-September 2004 (AS + SP)	0.042	[0.028 - 0.057]
Kilombero-Ulanga
An funestus	January 2002-February 2003 (SP)	0.034	[−0.001 - 0.025]
	March 2003-August 2004 (SP)	0.019	[−0.001 - 0.021]
An gambiae s.l.	January 2002-February 2003 (SP)	0.032	[0.000 - 0.020]
	March 2003-August 2004 (SP)	0.024	[−0.005 - 0.025]

ISSN: 1475-2875